Page tree
Skip to end of metadata
Go to start of metadata

NB. The Base64 PDF content in the example below has been cut. Refer to the following to link for a full example. 20180807 - ProstateExample3-PDF.ORU

MSH|^~\&|MOADLEDIT^MOADLEDIT:3.1.2 (Build 6381) [win32-i386]^L|Unassigned^8D9FE669-4710-455D-8B97-811508B616E7^GUID|||20161019162427+1100||ORU^R01^ORU_R01|XX10191624300-4735|P|2.4^AUS&Australia&ISO3166_1^HL7AU-OO-201701&&L|||AL|AL|AUS
PID|1||||CITIZEN^GEORGE||19640701|M|||C/o Paradise Close^^NAR NAR GOON^VIC^3812^AUS
PV1|1|O|||||||419786CW^CRUICE^ANTHONY^^^DR^^^AUSHICPR^L^^^UPIN
ORC|RE||92D0CE50-173A-4A2F-A3B1-6165376F222B^Unassigned^8D9FE669-4710-455D-8B97-811508B616E7^GUID||CM|||||||419786CW^CRUICE^ANTHONY^^^DR^^^AUSHICPR^L^^^UPIN
OBR|1||92D0CE50-173A-4A2F-A3B1-6165376F222B^Unassigned^8D9FE669-4710-455D-8B97-811508B616E7^GUID|84908-3^Prostate Cancer Histopathology^LN||20161019+1100|20161019+1100|||||||||419786CW^CRUICE^ANTHONY^^^DR^^^AUSHICPR^L^^^UPIN||||LN=92D0CE50-173A-4A2F-A3B1-6165376F222B||201610191609+1100||PHY|F||^^^20161019+1100|419786CW^CRUICE^ANTHONY^^^DR^^^AUSHICPR^L^^^UPIN~921198YF^SMITH^MICHAEL^^^DR^^^AUSHICPR^L^^^UPIN
OBX|1|RP|60572-5^^LN^ENTRY^^EN 13606|1|CEN.RCPA-ProstateCancer_(Rad_Prostatectomy).v2^Prostate Cancer Histopathology&99A-F4ADB3A91A896333&L^TX^Octet-stream||||||F
OBX|2|CE|70949-3^^LN^CLUSTER^^EN 13606|1.1|70949-3^Clinical details^LN||||||F
OBX|3|ST|29306-8^Surgical procedure^LN|1.1.2|Radical prostatectomy||||||F
OBX|4|ST|55752-0^Clinical information^LN|1.1.4|PCa G6 - prostate and seminal vesicles - left and right pelvic nodes - pre-prostatic fat - left apical margin - left lateral margin||||||F
OBX|5|NM|2857-1^Pre-biopsy serum PSA^LN|1.1.6|5.9|ug/L^^ISO+|||||F
OBX|6|ST|LN-RCPA-00085^Relevant clinical information for clinicopathological staging^L|1.1.8|Core biopsy Gleason score: 3+3=6||||||F
OBX|7|ST|57723-9^Pathology accession number^LN|1.1.9|89470-15MP||||||F
OBX|8|ST|18600-7^Principal clinician^LN|1.1.10|Dr Smith||||||F
OBX|9|CE|70949-3^^LN^CLUSTER^^EN 13606|1.2|70949-3^Macroscopic findings^LN||||||F
OBX|10|NM|29638-4^Specimen weight^LN|1.2.1|60|g^^ISO+|||||F
OBX|11|CE|70949-3^^LN^CLUSTER^^EN 13606|1.2.2|LN-RCPA-00086^Specimen dimensions (prostate)^L||||||F
OBX|12|NM|LN-RCPA-00100^Length^L|1.2.2.1|51|mm^^ISO+|||||F
OBX|13|NM|LN-RCPA-00101^Width^L|1.2.2.2|47|mm^^ISO+|||||F
OBX|14|NM|LN-RCPA-00102^Thickness^L|1.2.2.3|42|mm^^ISO+|||||F
OBX|15|CE|LN-RCPA-00087^Seminal vesicles^L|1.2.3|at0196^Present^99A-F4ADB3A91A896333||||||F
OBX|16|CE|LN-RCPA-00088^Lymph nodes^L|1.2.4|52101004^Present^SCT||||||F
OBX|17|CE|20228-3^Laterality^LN|1.2.5|51440002^Bilateral^SCT||||||F
OBX|18|CE|70949-3^^LN^CLUSTER^^EN 13606|1.2.6.1|at0024^Site(s) and numbers of lymph nodes^99A-F4ADB3A91A896333||||||F
OBX|19|ST|39111-0^Site^LN|1.2.6.1.1|Left pelvic||||||F
OBX|20|NM|21894-1^Number of LNs from this site^LN|1.2.6.1.2|1||||||F
OBX|21|ST|39111-0^Site 2^LN|1.2.6.1.3|Right pelvic||||||F
OBX|22|NM|21894-1^Number of LNs from this site^LN|1.2.6.1.4|1||||||F
OBX|23|ST|22634-0^Additional macroscopic  comments^LN|1.2.8|Volume: 0.6cm3 (3D volume estimate method)||||||F
OBX|24|CE|70949-3^^LN^CLUSTER^^EN 13606|1.3|70949-3^Microscopic findings^LN||||||F
OBX|25|CE|44639-3^Histological tumour type^LN|1.3.1|45410002^Adenocarcinoma (Acinar, usual type)^SCT||||||F
OBX|26|CE|70949-3^^LN^CLUSTER^^EN 13606|1.3.4|at0093^Tumour location^99A-F4ADB3A91A896333||||||F
OBX|27|CE|70949-3^^LN^CLUSTER^^EN 13606|1.3.4.4|LN-RCPA-00092^Locations by quadrant^L||||||F
OBX|28|CE|264176005^Right anterior^SCT|1.3.4.4.1|31874001^Yes^SCT||||||F
OBX|29|CE|277593009^Right posterior^SCT|1.3.4.4.2|31874001^Yes^SCT||||||F
OBX|30|CE|264065008^Left anterior^SCT|1.3.4.4.3|31874001^Yes^SCT||||||F
OBX|31|CE|277594003^Left posterior^SCT|1.3.4.4.4|31874001^Yes^SCT||||||F
OBX|32|CE|70949-3^^LN^CLUSTER^^EN 13606|1.3.4.5|LN-RCPA-00090^Locations by plane^L||||||F
OBX|33|CE|68756004^Apex^SCT|1.3.4.5.1|64100000^No^SCT||||||F
OBX|34|CE|279704000^Mid^SCT|1.3.4.5.2|64100000^No^SCT||||||F
OBX|35|CE|36082003^Base of prostate^SCT|1.3.4.5.3|64100000^No^SCT||||||F
OBX|36|CE|70949-3^^LN^CLUSTER^^EN 13606|1.3.7|372278000^Histological tumour grade^SCT||||||F
OBX|37|NM|44641-9^Primary Gleason grade^LN|1.3.7.1|3||||||F
OBX|38|NM|44642-7^Secondary Gleason grade^LN|1.3.7.2|4||||||F
OBX|39|CE|385432009^Tertiary Gleason grade not applicable^SCT|1.3.7.4|64100000^No^SCT||||||F
OBX|40|FT|35266-6^Gleason score^LN^372278000^^SCT|1.3.7.5|3+4=7\.br\Composite Gleason Score (ISUP) 2005): 3+4=7 \.br\Index carcinoma score (ISUP 2005): 3+4=7 % \.br\High Grade (4/5): 5%. \.br\Intraduct carcinoma: Absent.||||||F
OBX|41|CE|LN-RCPA-00096^Extent^L|1.3.9|420366008^Focal^SCT||||||F
OBX|42|CE|70949-3^^LN^CLUSTER^^EN 13606|1.3.10|LN-RCPA-00095^Location(s) of EPE^L||||||F
OBX|43|CE|at0138^Lateral^99A-F4ADB3A91A896333|1.3.10.1|64100000^No^SCT||||||F
OBX|44|CE|at0139^Postero-lateral^99A-F4ADB3A91A896333|1.3.10.2|64100000^No^SCT||||||F
OBX|45|CE|at0140^Posterior^99A-F4ADB3A91A896333|1.3.10.3|64100000^No^SCT||||||F
OBX|46|CE|at0141^Anterior^99A-F4ADB3A91A896333|1.3.10.4|64100000^No^SCT||||||F
OBX|47|CE|at0142^Bladder neck^99A-F4ADB3A91A896333|1.3.10.5|64100000^No^SCT||||||F
OBX|48|CE|at0143^Apical^99A-F4ADB3A91A896333|1.3.10.6|64100000^No^SCT||||||F
OBX|49|CE|at0144^Other^99A-F4ADB3A91A896333|1.3.10.7|64100000^No^SCT||||||F
OBX|50|CE|44670-8^Margin status^LN|1.3.11|55182004^Not involved^SCT||||||F
OBX|51|CE|44626-0^Seminal vesicles^LN|1.3.16|at0160^Not involved^99A-F4ADB3A91A896333||||||F
OBX|52|CE|70949-3^^LN^CLUSTER^^EN 13606|1.3.19|23.02.28965^Lymph node status^RCPA||||||F
OBX|53|NM|44621-1^Number of lymph nodes examined^LN|1.3.19.1|1||||||F
OBX|54|NM|21893-3^Number of positive lymph nodes^LN|1.3.19.2|0||||||F
OBX|55|CE|59544-7^Lymphovascular invasion^LN|1.3.20|at0171^Not identified^99A-F4ADB3A91A896333||||||F
OBX|56|CE|70949-3^^LN^CLUSTER^^EN 13606|1.4|70949-3^Synthesis and overview^LN||||||F
OBX|57|CE|70949-3^^LN^CLUSTER^^EN 13606|1.4.1|21902-2^Pathological staging (AJCC 7th Ed)^LN||||||F
OBX|58|CE|21899-0^Primary tumour (T)^LN|1.4.1.1|at0176^T2  Organ Confined^L||||||F
OBX|59|CE|70949-3^^LN^CLUSTER^^EN 13606|1.4.2|67203-0^Year and edition of staging system^LN||||||F
OBX|60|ST|at0106^Year^99A-F4ADB3A91A896333|1.4.2.1|AJCC 2005||||||F
OBX|61|ST|at0107^Edition^99A-F4ADB3A91A896333|1.4.2.2|7th Ed||||||F
OBX|62|FT|34574-4^Diagnostic summary^LN|1.4.3|1. Radical prostatectomy: Prostatic adenocarcinoma \.br\2. Left pelvic lymph node: Fibradipose tissue only \.br\3. Right pelvic lymph node: No evidence of malignancy \.br\4. Periprostatic tissue: No evidence of malignancy \.br\5. Left apical margin: No evidence of mailgnancy 6. Left lateral margin: No evidence of malignancy||||||F
OBX|63|ED|PDF^Display format in PDF^AUSPDI||ECLIPSE&ECLIPSE:3.1.8 [win32-i386]&L^application^pdf^Base64^JVB...UlRU9GDQo=||||||F
  • No labels